期刊文献+

血清IgG4检测在膜性肾病诊断及鉴别诊断中的意义 被引量:1

Serum IgG4 to diagnosis and differential diagnosis of membranous nephropathy
原文传递
导出
摘要 目的分析血清IgG4水平对原发性膜性肾病(IMN)诊断及其与继发性膜性肾病(SMN)患者诊断和鉴别诊断的意义。方法检测28例膜性肾病患者(其中IMN21例,SMN7例)血清IgG4水平,并行尿蛋白测定及相关血生化检测,对其结果进行分析比较。结果IMN组和SMN组血清IgG4水平(分别为2373.86.g/L±1156.59ng/L和1321.57ng/L±1330.28ng/L)比较有显著性差异(P〈0.01),两组尿蛋白定量(分别为6.46g/a±6.41g/d和5.74g/d±3.53g/d)比较无显著性差异(P〉0.05),而两组主要血生化指标比较也无显著差异(P〉0.05)。结论血清IgG4水平检测可作为临床IMN的诊断及其与SMN鉴别诊断的指标之一。 Objectives To explore the clinical significance of seruro IgG4 in the diagnosis and differential diagnosis of idiopathic membranous nephrepathy ( IMN ) and secondary membranous nephropathy(SMN). Methods The serum IgG4 concentrations of 21 IMN patients and 7 SMN patients were detected by ELISA, urinary protein concentrations and main serum biochemistry parameters were measured, and analysed their correlation. Results The serum IgG4 levels of IMN patients are significantly higher than the SMN patients, (2373.86 ng/L + 1156.59 ng/ L and 1321.57 ng/L ± 1330.28 ng/L,respectively,P 〈0.01 ) ;urinary protein concentrations of two groups (6.46 g/ d ± 6.41 g/d and 5.74 g/d ± 3.53 g/d, respectively)and main serum biochemistry parameters have no significant difference( P 〉 0.05 ). Conclusions Serum IgG4 might be a useful indicator to diagnosis and differential diagnosis of IMN and SMN.
出处 《国际泌尿系统杂志》 2013年第3期314-316,共3页 International Journal of Urology and Nephrology
关键词 肾疾病 IGG4 Kidney Diseases IgG4
  • 相关文献

参考文献10

  • 1Waldman M, Austin HA 3rd. Controversies in the treatment of Idio- pathic membranous nephropathy. Nat Rev Nephrol, 2009,5 ( 8 ) :469 -479.
  • 2Ronco P, Debiec H. Antigen identification in membranous nephrop- athy moves toward targeted monitoring and new therapy. J Am Soc Nephrol,2010,21 (4) :564 -569.
  • 3Beck LH Jr, Boneqio RG, Lambean G, et al. M - type phospho- lipase A2 receptor as target antigen in idiopathic membranous ne- phropathy. N Engl J Med,2009,361 ( 1 ) : 11 - 21.
  • 4Ronco P, Debiec H. Pathophysiological lessons from rare associa- tions of immunological disorders. Pediatr Nephro1,2009 ,24 :3 - 8.
  • 5Prunotto M, Carnevali ML, Candiano G, et al. Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J Am Soc Nephrol,2010,21 ( 3 ) :507 - 519.
  • 6Ronco P, Debiec H. Pathophysiological lessons from rare associa- tions of immunological dimmers. Pediatr Nephrol, 2009,24 ( 1 ) : 3 -8.
  • 7刘志红,黎磊石.中国肾脏病学.人民军医出版社,2008,387-401.
  • 8Kawasaki Y,SuzukiJ,SakaiN,et al. Evaluation of T helper - 1/- 2 balance on the basis of IgG subclasses and serum cytokines in children with glomemlonephritis. Am J Kidney Dis,2004,44 ( 1 ) : 42 - 49.
  • 9何志军,杨琪,潘涛.IgG亚型在乙型肝炎病毒相关性膜性肾病与特发性膜性肾病肾小球中沉积特点的研究[J].诊断病理学杂志,2007,14(6):464-465. 被引量:12
  • 10汤绚丽,鲁盈,朱晓玲,胡云琴,王永钧,闵曼.IgG亚型在鉴别膜性肾病病因中的意义[J].中华肾脏病杂志,2010,26(8):634-636. 被引量:17

二级参考文献15

  • 1顾越英,叶霜.狼疮肾炎病理分型新进展的启示[J].中华风湿病学杂志,2004,8(9):513-514. 被引量:31
  • 2吴燕,刘志红.特发性膜性肾病的诊断及治疗规范[J].肾脏病与透析肾移植杂志,2004,13(6):558-559. 被引量:30
  • 3中华内科杂志编委会.乙型肝炎病毒相关性肾炎座谈会纪要[J].中华内科杂志,1990,29:519-519.
  • 4Doi T,Mayumi M,Kanatsu K,et al.Distribution of IgG subclasses in membranous nephropathy.Clin Exp Immunol,1984,58:57-62.
  • 5Verger MF,Droz D,Vantelon J.Autoimmune thyroid diseases associated with glomerular nephropathy,3 cases.Presse Med,1983,12:83-86.
  • 6Ohtani H,Wakui H,Komatsuda A,et al.Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy.Nephrol Dial Transplant,2004,19:574-579.
  • 7Imai H,Hamai K,Komatsuda A,et al.IgG subclasses in patients with membranoproliferative glomerulonephritis,membranous nephropathy,and lupus nephritis.Kidney Int,1997,51:270-276.
  • 8Kuroki A,Shi data T,Honda H,et al.Clomerular and serum IgG subclasses in diffuse proliferative lupus nephritis,membranous lupus nephritis,and idiopathic membranous nephropathy.Intern Med,2002,41:936-942.
  • 9Kawasaki Y,Suzuki J,Sakai N,et al.Evaluation of T helper-1/-2 balance on the basis of IgC subclasses and serum cytokines in children with glomerulonephritis.Am J Kidney Dis,2004,44:42-49.
  • 10邹万忠.肾活检的临床病理诊断[A].肾脏病临床与进展[M].北京:人民卫生出版社,2005.32-33.

共引文献22

同被引文献1

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部